|1.||Chan, Ivan S F: 12 articles (03/2015 - 02/2007)|
|2.||Levin, Myron J: 11 articles (03/2015 - 09/2007)|
|3.||Harpaz, Rafael: 9 articles (10/2015 - 03/2008)|
|4.||Oxman, Michael N: 8 articles (03/2015 - 06/2009)|
|5.||Tseng, Hung Fu: 7 articles (10/2015 - 01/2011)|
|6.||Jacobsen, Steven J: 7 articles (10/2015 - 01/2011)|
|7.||Sy, Lina S: 6 articles (10/2015 - 11/2007)|
|8.||Johnson, Gary R: 6 articles (03/2015 - 10/2009)|
|9.||Zhang, Jane H: 6 articles (03/2015 - 10/2009)|
|10.||Shingles Prevention Study Group: 6 articles (03/2015 - 06/2005)|
10/01/2009 - "Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine."
02/01/2008 - "The Shingles Prevention Study established that the zoster vaccine was safe, well tolerated, and effective in reducing the burden of illness due to herpes zoster and the incidence of PHN. "
04/01/2013 - "The new zoster vaccine has been shown to be effective in reducing the incidence of herpes zoster and PHN."
01/01/2012 - "Herpes zoster vaccine is effective in preventing herpes zoster disease. "
06/01/2010 - "Zostavax is a new vaccine effective for preventing shingles and PHN. "
12/01/2007 - "Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia."
10/01/2013 - "Live attenuated zoster vaccine is safe and efficacious in preventing HZ and decreasing the morbidity associated with postherpetic neuralgia. "
04/01/2006 - "Importantly, the incidence of postherpetic neuralgia is significantly reduced in patients who receive zoster vaccine, irrespective of age or sex. "
01/01/2006 - "Zoster vaccine to prevent postherpetic neuralgia."
05/04/2010 - "The herpes zoster vaccine is effective in preventing herpes zoster and postherpetic neuralgia in immunocompetent older adults. "
|3.||Neuralgia (Stump Neuralgia)
08/01/2009 - "A zoster vaccine is now available that boosts the CMI immune reaction to VZV in individuals and has proven safe and partially effective in preventing both HZ and post-herpetic neuralgia. "
06/01/2015 - "The protective efficacy of the attenuated herpes zoster vaccine was evaluated in the Shingles Prevention Study, which showed that in the short term (0-4 years) the vaccine reduced the incidence of herpes zoster by 53%, post-herpetic neuralgia by 66%, and the disease burden in immunocompetent persons aged ≥60 years by 61%. "
08/01/2006 - "Results from several clinical trials have determined that a live, attenuated VZV vaccine using the Oka/Merck strain (Zostavax) is safe, elevates VZV-specific cell-mediated immunity, and significantly reduces the incidence of herpes zoster and post-herpetic neuralgia in people over 60 years of age. "
07/01/2006 - "Finally, a recent study using a live zoster vaccine with increased antigenicity in older adults halved the incidence of herpes zoster and reduced that of post-herpetic neuralgia to one-third."
07/01/2013 - "Vaccination with the zoster vaccine is recommended for most people older than 60, and reduces the incidence of herpes zoster and the occurrence of post-herpetic neuralgia. "
10/01/2010 - "On the eve of probable introduction of the Varicella Zoster Vaccine (VZ-V) into the INVP a study was conducted to examine factors postulated to be of importance in vaccination uptake. "
01/01/2006 - "[Study tests Varicella-Zoster vaccine for over 60-years-old persons. "
06/01/1983 - "[Preliminary study of an attenuated varicella-zoster vaccine (Webster strain) in 27 children without immunologic disorders]."
01/01/2016 - "Two doses of live-attenuated varicella-zoster vaccine are recommended for human immunodeficiency virus 1 (HIV-1)-infected children with CD4% ≥15%. "
04/01/2015 - "The least-effective vaccine currently recommended is the varicella-zoster vaccine, with a 50% efficacy. "
08/01/2007 - "The zoster vaccine is effective in reducing pain burden and preventing HZ and PHN in older adults."
01/01/2007 - "Is there a role for herpes zoster vaccine in chronic pain management?."
01/01/2015 - "Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status."
01/01/2015 - "Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 Update and consensus statement from the Canadian Pain Society."
06/01/2011 - "Prevention strategies for PHN include administration of zoster vaccine, treatment with antiviral therapy within 72 hours of rash onset and aggressive pain control. "
|1.||Herpes Zoster Vaccine
|2.||Chickenpox Vaccine (Vaccine, Varicella)
|5.||Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)
|6.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||Influenza Vaccines (FluMist)
|8.||Tetanus Toxoid (Vaccine, Tetanus)
|9.||Diphtheria Toxoid (Vaccine, Diphtheria)
|10.||Measles-Mumps-Rubella Vaccine (MMR Vaccine)
|1.||Drug Therapy (Chemotherapy)
|2.||Activities of Daily Living (ADL)
|4.||Hematopoietic Stem Cell Transplantation